Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
The University of Texas Health Science Center, Houston |
---|---|
Information provided by: | The University of Texas Health Science Center, Houston |
ClinicalTrials.gov Identifier: | NCT00581425 |
A trial to see if BCC excluding the scalp and face can be treated successfully with a combination therapy of Intron-A and Aldara.
Condition | Intervention | Phase |
---|---|---|
Basal Cell Carcinoma |
Biological: Imiquimod and Interferon alpha |
Phase IV |
Study Type: | Interventional |
Study Design: | Treatment, Open Label, Historical Control, Single Group Assignment, Efficacy Study |
Official Title: | Intron-A/Aldara Combination Therapy for BCC Excluding the Face and Scalp |
Estimated Enrollment: | 40 |
Study Start Date: | December 2007 |
Estimated Study Completion Date: | December 2010 |
Estimated Primary Completion Date: | December 2008 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
Treated: Experimental |
Biological: Imiquimod and Interferon alpha
Imiquimod first two weeks and last two weeks. Interferon middle five weeks.
|
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Stephen B Tucker, M.D. | 281-773-6774 | stephen.b.tucker@uth.tmc.edu |
United States, Texas | |
University of Texas Health Science Center of Houston Dermatology Clinic | Recruiting |
Houston, Texas, United States, 77030 | |
Contact: Stephen B Tucker, M.D. 281-773-6774 stephen.b.tucker@uth.tmc.edu |
Principal Investigator: | Stephen B Tucker, M.D. | University of Texas Health Science Center of Houston Dermatology Clinic |
Responsible Party: | The University of Texas Health Science Center, Houston ( Stephen B. Tucker, M.D. ) |
Study ID Numbers: | HSC-MS-06-0478, OSP-24412 |
Study First Received: | December 21, 2007 |
Last Updated: | July 23, 2008 |
ClinicalTrials.gov Identifier: | NCT00581425 |
Health Authority: | United States: Institutional Review Board |
BCC Basal Cell Carcinoma Intron-A Aldara Basal Cell Carcinoma excluding scalp and face |
Interferon-alpha Facies Interferons Imiquimod Carcinoma, Basal Cell |
Interferon Alfa-2a Interferon Alfa-2b Neoplasms, Glandular and Epithelial Carcinoma |
Interferon Inducers Anti-Infective Agents Neoplasms by Histologic Type Immunologic Factors Antineoplastic Agents Growth Substances Physiological Effects of Drugs Adjuvants, Immunologic |
Antiviral Agents Angiogenesis Inhibitors Pharmacologic Actions Neoplasms Therapeutic Uses Neoplasms, Basal Cell Angiogenesis Modulating Agents Growth Inhibitors |